Stock listing

OTC:ZIVO Zivo Bioscience, Inc. Stock

Follow Zivo Bioscience, Inc. into a list and get an email when it puts out news.

Share price · OTC:ZIVO

$5.50 USD 0.00 (0.0%)

Close on Nov 20, 2026

Past year -39.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$5.50 – $5.50 USDNov 20, 2026
Volume
100 sharesNov 20, 2026
Market cap
$23.18M USDAt the close on Nov 20, 2026 · price × 4.22M shares outstanding
52-week range
$1.11 – $12.04 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$2,746 USDMedian day 200 shares · 21 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Zivo Bioscience, Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OTC:ZIVO · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$5.500.000.0%$5.50$5.50$5.50100
$5.500.000.0%$5.25$5.50$5.25529
$5.50-0.25-4.3%$5.85$5.99$5.50337
$5.75-0.25-4.2%$5.75$5.75$5.7513
$6.00-1.25-17.2%$5.76$6.00$5.7650
$7.25-0.75-9.4%$8.12$8.12$7.2535
$8.00+0.75+10.3%$10.49$10.49$8.0030
$7.25-0.87-10.7%$7.25$7.25$7.25134
$8.12-0.47-5.5%$8.12$8.12$8.12200
$8.59+1.34+18.5%$9.24$9.24$8.272,100
$7.25+1.00+16.0%$7.00$7.25$7.00400
$6.250.000.0%$6.25$6.25$6.250
$6.250.000.0%$6.25$6.25$6.250
$6.25+0.10+1.6%$6.25$6.25$6.25200
$6.15-0.65-9.6%$6.23$6.23$6.151,000
$6.800.000.0%$6.80$6.80$6.800
$6.800.000.0%$6.80$6.80$6.800
$6.80+0.30+4.6%$6.50$6.80$6.501,000
$6.50-0.01-0.2%$6.91$6.91$6.501,900
$6.510.000.0%$6.51$6.51$6.519
$6.510.000.0%$6.51$6.51$6.510
$6.51+1.21+22.8%$6.19$6.51$6.191,900
$5.300.000.0%$5.30$5.30$5.300
$5.30+1.06+25.0%$4.40$5.31$4.403,900
$4.24+0.14+3.4%$4.19$4.30$4.19400
$4.100.000.0%$4.10$4.10$4.10200
$4.100.000.0%$4.10$4.10$4.100
$4.10+0.09+2.2%$3.94$4.15$3.941,700
$4.01+0.47+13.3%$3.60$4.01$3.601,100
$3.54+0.24+7.3%$3.35$3.55$3.351,600
$3.300.000.0%$3.30$3.30$3.300
$3.300.000.0%$3.30$3.30$3.300
$3.300.000.0%$3.30$3.30$3.300
$3.30-0.30-8.3%$3.51$3.51$3.30400
$3.600.000.0%$3.60$3.60$3.600
$3.60+0.05+1.4%$3.80$3.80$3.512,000
$3.55+0.35+10.9%$3.25$3.55$3.25900
$3.200.000.0%$3.20$3.20$3.20200
$3.20+0.01+0.3%$3.20$3.20$3.20200
$3.19-0.16-4.8%$3.35$3.35$3.19600
$3.35-0.75-18.3%$4.00$4.00$3.351,900
$4.100.000.0%$4.10$4.10$4.100
$4.100.000.0%$4.10$4.10$4.101
$4.10+0.50+13.9%$3.80$4.15$3.801,700
$3.60+0.49+15.8%$3.33$3.60$3.33500
$3.110.000.0%$3.11$3.11$3.110
$3.11-0.49-13.6%$3.50$3.50$3.01800
$3.600.000.0%$3.60$3.60$3.600
$3.60-0.35-8.9%$3.95$3.95$3.601,700
$3.950.000.0%$3.95$3.95$3.950
$3.95-0.32-7.5%$3.96$3.96$3.95300
$4.270.000.0%$4.27$4.27$4.270
$4.270.000.0%$4.27$4.27$4.270
$4.270.000.0%$4.27$4.27$4.270
$4.270.000.0%$4.27$4.27$4.270
$4.270.000.0%$4.27$4.27$4.270
$4.27+0.02+0.5%$4.32$4.33$4.272,700
$4.25+0.30+7.6%$4.30$4.30$4.25400
$3.950.000.0%$3.95$3.95$3.950

Splits

1 split · OTC:ZIVO · every price before a split is adjusted for it

DayRatioWhat
1-for-6Consolidation
Ticker
OTC:ZIVO
Asset type
Stock
Exchange
OTC
Currency
USD

Zivo Bioscience, Inc. on 6ix

Decks
10 decks · latest January 2025

Valuation

balance Sep 30, 2025 · price Nov 20, 2026

Enterprise value
$23.13M USD
P/E
Not reported
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
Negative equity
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
Negative equity
Beta vs S&P 500
0.67

Forecasts

1 hold · Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.

Price target
12.00 USD · Analysts' mean
EPS, year to Dec 2025
-2.10 · 1 analyst

Team and board

Officers

OfficerRole
John B. PaynePresident / Chief Executive Officer / Chairman of the Board
Amy SteffekDirector, Research & Development

Board

DirectorRole
John B. PaynePresident / Chief Executive Officer / Chairman of the Board
Christopher MaggioreDirector since 2013
Laith YaldooDirector since 2024

Events

QuarterResultsShare move
Quarter to Jun 30, 2026Sep 2, 2026−8.9%
Quarter to Mar 31, 2026Jun 3, 2026−15.4%
Quarter to Dec 31, 2025Feb 25, 2026−2.6%
Q3 2025Nov 14, 2025 · After close−2.9%
Q2 2025Aug 14, 2025 · After close+0.2%
Q1 2025May 15, 2025 · After close0.0%
Q4 2024Mar 13, 2025 · After close0.0%
Q3 2024Nov 14, 2024 · After close−0.2%
Q2 2024Aug 14, 2024 · After close−20.8%
Q1 2024May 13, 2024 · After close0.0%
All 20 quarters
QuarterResultsShare move
Q4 2023Feb 28, 2024−6.9%
Q3 2023Nov 13, 2023 · After close−3.5%
Q2 2023Aug 14, 2023 · After close−3.2%
Q1 2023May 10, 2023 · After close−2.2%
Q4 2022Mar 14, 2023 · After close−6.7%
Q3 2022Nov 14, 2022 · After close−1.4%
Q2 2022Aug 4, 2022 · After close0.0%
Q1 2022May 13, 2022 · After close−2.3%
Q4 2021Mar 2, 2022+1.7%
Q3 2021Nov 15, 2021 · After close−4.3%

Open Events

Decks

DeckKindSlidesDate
January 2025 Microcap ConferenceConference17 slidesJanuary 2025
Investor Presentation (August 2024)Investor deck15 slidesAugust 2024
Dawon James Small Cap Growth Conference (October 2023)Conference13 slidesOctober 2023
Investor Presentation (January 2023)Investor deck10 slidesJanuary 2023
Shareholder Meeting (October 2021)Shareholder meeting23 slidesOct 12, 2021
Non-Deal Roadshow (June 2021)Roadshow24 slidesJune 2021
Investor Presentation (March 2021)Investor deck17 slidesMar 17, 2021
Corporate Update (April 2020)Corporate update27 slidesApril 2020
Shareholder Meeting (May 2019)Shareholder meeting44 slidesMay 1, 2019
Biotech Showcase 2018Conference24 slidesJan 10, 2018

Open Decks

Financials

Annual, in USD

Income statement

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Revenue157.2K27.6K0020.0K00000
Cost of revenue108.3K16.0K0
Gross profit49.0K11.6K0
Research and development3.13M1.38M2.24M1.95M3.75M2.31M2.81M2.38M789.0K1.03M
Operating income-13.4M-7.26M-8.73M-8.65M-8.56M-8.35M-6.13M-6.33M-3.49M-3.06M
Depreciation and amortization000018.8K25.0K25.0K
EBITDA-8.65M-8.56M-8.35M-6.13M-6.31M-3.47M-3.03M
Interest expense23.8K13.3K44.7K97.6K-35.5K-2.40K
Net income-13.4M-7.78M-8.75M-8.76M-9.11M-11.5M-14.6M-10.0M-6.06M-5.79M
Earnings per share, basic-3.70-3.26-5.57-0.93-0.02-0.04-0.09-0.07-0.05-0.04
Earnings per share, diluted-4.23-4.60-0.02-0.04-0.09-0.07-0.05-0.04

Balance sheet

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash and equivalents1.54M274.4K1.80M8.90M137.9K346.1K388.9K317.1K507.0K16.6K
Receivables0
Current assets1.64M425.4K1.90M8.96M167.8K369.4K411.5K332.3K520.4K28.9K
Property, plant and equipment000000018.8K43.8K
Total assets1.64M555.7K2.12M8.99M220.2K369.4K411.5K332.3K737.3K72.7K
Accounts payable547.1K993.1K490.7K654.3K1.56M1.37M422.4K541.7K666.4K1.11M
Current liabilities2.04M2.76M2.03M2.95M11.4M8.71M22.7M4.56M11.2M4.97M
Total debt00105.9K0
Total liabilities2.16M2.76M2.13M2.95M11.5M8.71M22.7M16.6M14.4M9.57M
Shareholders' equity-514.9K-2.21M-10.6K6.04M-11.3M-8.34M-22.3M-16.3M-13.6M-9.50M
Shares outstanding3.62M2.38M1.57M9.42M5.16M413.0M180.0M141.1M136.7M132.2M

Cash flow

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operations-4.31M-5.80M-7.10M-6.80M-2.59M-3.71M-5.01M-4.24M-2.54M-2.30M
Cash from investing0000000000
Cash from financing5.58M4.28M015.6M2.38M3.66M5.08M4.05M3.03M2.31M
Change in cash1.27M-1.52M-7.10M8.76M-208.2K490.4K15.2K

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipApr 24, 2026Insider tradeSEC
EFFECT · Notice that a registration is effectiveApr 2, 2026Other filingsSEC
15-12GMar 30, 2026Other filingsSEC
S-8 POSMar 30, 2026Offer documentSEC
POS AM · Amendment to an effective registrationMar 30, 2026Offer documentSEC
8-K · Current reportMar 30, 2026Management or board changeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedFeb 27, 2026Big-stake noticeSEC
4 · Change in ownershipFeb 17, 2026Insider tradeSEC
4 · Change in ownershipFeb 12, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipJan 28, 2026Insider tradeSEC
4 · Change in ownershipJan 28, 2026Insider tradeSEC
4 · Change in ownershipJan 27, 2026Insider tradeSEC
4 · Change in ownershipJan 27, 2026Insider tradeSEC
3 · Initial statement of ownershipDec 29, 2025Insider tradeSEC
8-K · Current reportDec 23, 2025Management or board changeSEC
4 · Change in ownershipDec 2, 2025Insider tradeSEC
10-Q · Quarterly reportNov 14, 2025Quarterly reportSEC
4 · Change in ownershipOct 20, 2025Insider tradeSEC
4 · Change in ownershipOct 14, 2025Insider tradeSEC
4 · Change in ownershipOct 9, 2025Insider tradeSEC
4 · Change in ownershipOct 6, 2025Insider tradeSEC
4 · Change in ownershipOct 6, 2025Insider tradeSEC
4 · Change in ownershipOct 6, 2025Insider tradeSEC
4 · Change in ownershipOct 2, 2025Insider tradeSEC
8-K · Current reportSep 10, 2025Current reportSEC
8-K · Current reportAug 18, 2025Management or board changeSEC
10-Q · Quarterly reportAug 14, 2025Quarterly reportSEC
8-K · Current reportJul 14, 2025Material contractSEC
4 · Change in ownershipJun 16, 2025Insider tradeSEC
8-K · Current reportJun 11, 2025Meeting outcomeSEC
10-Q · Quarterly reportMay 15, 2025Quarterly reportSEC
DEF 14A · Proxy statementApr 25, 2025Meeting noticeSEC
ARS · Annual report to shareholdersApr 25, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 25, 2025Meeting noticeSEC
4 · Change in ownershipApr 9, 2025Insider tradeSEC
4 · Change in ownershipApr 4, 2025Insider tradeSEC
10-K · Annual reportMar 18, 2025Annual reportSEC
8-K · Current reportJan 27, 2025FinancingSEC
5 · Annual statement of ownershipJan 23, 2025Insider tradeSEC
4 · Change in ownershipJan 21, 2025Insider tradeSEC
8-K · Current reportJan 15, 2025Material contractSEC
8-K · Current reportJan 7, 2025Current reportSEC
4 · Change in ownershipJan 3, 2025Insider tradeSEC
4 · Change in ownershipJan 3, 2025Insider tradeSEC
4 · Change in ownershipJan 3, 2025Insider tradeSEC
4 · Change in ownershipJan 3, 2025Insider tradeSEC
4 · Change in ownershipDec 31, 2024Insider tradeSEC
8-K · Current reportNov 15, 2024Material contractSEC
10-Q · Quarterly reportNov 14, 2024Quarterly reportSEC
8-K · Current reportOct 18, 2024FinancingSEC
4 · Change in ownershipOct 17, 2024Insider tradeSEC
4 · Change in ownershipOct 16, 2024Insider tradeSEC
3 · Initial statement of ownershipOct 1, 2024Insider tradeSEC
SC 13D/A · Big-stake notice, amendedOct 1, 2024Big-stake noticeSEC
4 · Change in ownershipAug 23, 2024Insider tradeSEC
4 · Change in ownershipAug 23, 2024Insider tradeSEC
10-Q · Quarterly reportAug 14, 2024Quarterly reportSEC
4 · Change in ownershipJul 30, 2024Insider tradeSEC
8-K · Current reportJul 17, 2024Management or board changeSEC
4 · Change in ownershipJun 13, 2024Insider tradeSEC
4 · Change in ownershipJun 13, 2024Insider tradeSEC
4 · Change in ownershipJun 13, 2024Insider tradeSEC
8-K · Current reportJun 13, 2024Meeting outcomeSEC
SC 13D · Big-stake noticeJun 12, 2024Big-stake noticeSEC
SC 13D · Big-stake noticeJun 12, 2024Big-stake noticeSEC
SC 13D · Big-stake noticeJun 12, 2024Big-stake noticeSEC
SC 13D/A · Big-stake notice, amendedJun 7, 2024Big-stake noticeSEC
8-K/A · Current report, amendedJun 7, 2024Material contractSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
8-K · Current reportJun 6, 2024Material contractSEC
UPLOAD · Letter from the SECJun 5, 2024Other filingsSEC
4 · Change in ownershipJun 4, 2024Insider tradeSEC
CORRESP · Letter to the SECMay 31, 2024Other filingsSEC
10-Q · Quarterly reportMay 13, 2024Quarterly reportSEC
UPLOAD · Letter from the SECMay 3, 2024Other filingsSEC
ARS · Annual report to shareholdersApr 26, 2024Annual reportSEC
DEFA14A · Additional proxy materialApr 26, 2024Meeting noticeSEC
DEF 14A · Proxy statementApr 26, 2024Meeting noticeSEC
SC 13D/A · Big-stake notice, amendedApr 9, 2024Big-stake noticeSEC
10-K · Annual reportMar 15, 2024Annual reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedMar 14, 2024Big-stake noticeSEC
8-K · Current reportFeb 15, 2024Current reportSEC
25-NSEFeb 15, 2024Other filingsSEC
SC 13D · Big-stake noticeJan 22, 2024Big-stake noticeSEC
8-K · Current reportJan 17, 2024FinancingSEC
8-K · Current reportJan 5, 2024FinancingSEC
4 · Change in ownershipJan 4, 2024Insider tradeSEC
8-K · Current reportJan 3, 2024FinancingSEC
4 · Change in ownershipJan 2, 2024Insider tradeSEC
4 · Change in ownershipDec 14, 2023Insider tradeSEC
8-K · Current reportDec 11, 2023FinancingSEC
RW · Request to withdraw a registrationDec 1, 2023Other filingsSEC
8-K · Current reportNov 27, 2023Current reportSEC
8-K · Current reportNov 22, 2023Material contractSEC
10-Q · Quarterly reportNov 13, 2023Quarterly reportSEC
S-1/A · Registration statement, amendedNov 3, 2023Offer documentSEC
S-1/A · Registration statement, amendedOct 31, 2023Offer documentSEC
4 · Change in ownershipOct 30, 2023Insider tradeSEC
SC 13D/A · Big-stake notice, amendedOct 30, 2023Big-stake noticeSEC
8-K · Current reportOct 26, 2023Current reportSEC
S-1 · Registration statementOct 4, 2023Offer documentSEC
10-Q · Quarterly reportAug 14, 2023Quarterly reportSEC
8-K · Current reportAug 9, 2023Current reportSEC
EFFECT · Notice that a registration is effectiveAug 4, 2023Other filingsSEC
424B3 · ProspectusAug 3, 2023Offer documentSEC
CORRESP · Letter to the SECAug 1, 2023Other filingsSEC
UPLOAD · Letter from the SECJul 31, 2023Other filingsSEC
S-3 · Registration statementJul 27, 2023Offer documentSEC
DJul 17, 2023Other filingsSEC
8-K · Current reportJul 6, 2023Material contractSEC
424B5 · ProspectusJul 5, 2023Offer documentSEC
RW · Request to withdraw a registrationJun 28, 2023Other filingsSEC
8-K · Current reportJun 15, 2023Meeting outcomeSEC
4 · Change in ownershipJun 14, 2023Insider tradeSEC
4 · Change in ownershipJun 14, 2023Insider tradeSEC
4 · Change in ownershipJun 14, 2023Insider tradeSEC
8-K · Current reportMay 26, 2023Current reportSEC
10-Q · Quarterly reportMay 10, 2023Quarterly reportSEC
ARS · Annual report to shareholdersApr 28, 2023Annual reportSEC
DEF 14A · Proxy statementApr 28, 2023Meeting noticeSEC
4 · Change in ownershipApr 5, 2023Insider tradeSEC
8-K · Current reportApr 5, 2023Material contractSEC
S-1 · Registration statementMar 22, 2023Offer documentSEC
10-K · Annual reportMar 14, 2023Annual reportSEC
4/A · Change in ownership, amendedFeb 14, 2023Insider tradeSEC
SC 13D/A · Big-stake notice, amendedFeb 14, 2023Big-stake noticeSEC
8-K · Current reportFeb 10, 2023Current reportSEC
4 · Change in ownershipDec 21, 2022Insider tradeSEC
4 · Change in ownershipDec 21, 2022Insider tradeSEC
4 · Change in ownershipDec 20, 2022Insider tradeSEC
4 · Change in ownershipDec 20, 2022Insider tradeSEC
4 · Change in ownershipDec 20, 2022Insider tradeSEC
4 · Change in ownershipDec 20, 2022Insider tradeSEC
4 · Change in ownershipDec 20, 2022Insider tradeSEC
4 · Change in ownershipDec 14, 2022Insider tradeSEC
4/A · Change in ownership, amendedDec 8, 2022Insider tradeSEC
4/A · Change in ownership, amendedDec 8, 2022Insider tradeSEC
8-K · Current reportNov 29, 2022Current reportSEC
10-Q · Quarterly reportNov 14, 2022Quarterly reportSEC
4 · Change in ownershipSep 19, 2022Insider tradeSEC
4 · Change in ownershipAug 31, 2022Insider tradeSEC
8-K · Current reportAug 23, 2022Current reportSEC
10-Q · Quarterly reportAug 4, 2022Quarterly reportSEC
8-K · Current reportAug 3, 2022Meeting outcomeSEC
4 · Change in ownershipAug 1, 2022Insider tradeSEC
4 · Change in ownershipAug 1, 2022Insider tradeSEC
4 · Change in ownershipAug 1, 2022Insider tradeSEC
8-K · Current reportJul 7, 2022Current reportSEC
DEF 14A · Proxy statementJul 5, 2022Meeting noticeSEC
8-K · Current reportJun 28, 2022Current reportSEC
S-8 · Registration statement for employee plansJun 22, 2022Offer documentSEC
8-K · Current reportMay 20, 2022Current reportSEC
10-Q · Quarterly reportMay 13, 2022Quarterly reportSEC
10-K/A · Annual report, amendedMay 2, 2022Annual reportSEC
8-K · Current reportApr 25, 2022Current reportSEC
10-K · Annual reportApr 22, 2022Annual reportSEC
10-Q/A · Quarterly report, amendedApr 20, 2022Quarterly reportSEC
8-K · Current reportApr 15, 2022Current reportSEC
NT 10-K · Late filing noticeMar 31, 2022Explanation requestSEC
8-K/A · Current report, amendedMar 1, 2022Management or board changeSEC
8-K · Current reportFeb 25, 2022Management or board changeSEC
8-K · Current reportFeb 16, 2022Management or board changeSEC
4 · Change in ownershipFeb 16, 2022Insider tradeSEC
4 · Change in ownershipJan 28, 2022Insider tradeSEC
4 · Change in ownershipJan 14, 2022Insider tradeSEC
8-K · Current reportJan 10, 2022Management or board changeSEC
8-K/A · Current report, amendedDec 9, 2021Current reportSEC
8-K · Current reportDec 9, 2021Current reportSEC
10-Q · Quarterly reportNov 15, 2021Quarterly reportSEC
4 · Change in ownershipOct 25, 2021Insider tradeSEC
4 · Change in ownershipOct 25, 2021Insider tradeSEC
4 · Change in ownershipOct 25, 2021Insider tradeSEC
4 · Change in ownershipOct 25, 2021Insider tradeSEC
4 · Change in ownershipOct 25, 2021Insider tradeSEC
4 · Change in ownershipOct 15, 2021Insider tradeSEC
4 · Change in ownershipOct 15, 2021Insider tradeSEC
4 · Change in ownershipOct 15, 2021Insider tradeSEC
4 · Change in ownershipOct 15, 2021Insider tradeSEC
8-K · Current reportOct 14, 2021Meeting outcomeSEC
8-K · Current reportOct 12, 2021Current reportSEC
4/A · Change in ownership, amendedSep 28, 2021Insider tradeSEC
DEFA14A · Additional proxy materialSep 22, 2021Meeting noticeSEC
8-K · Current reportSep 21, 2021Management or board changeSEC
8-K/A · Current report, amendedSep 16, 2021Meeting outcomeSEC
DEF 14A · Proxy statementSep 13, 2021Meeting noticeSEC
EFFECT · Notice that a registration is effectiveSep 7, 2021Other filingsSEC
CORRESP · Letter to the SECSep 1, 2021Other filingsSEC
UPLOAD · Letter from the SECAug 31, 2021Other filingsSEC
S-3 · Registration statementAug 26, 2021Offer documentSEC
10-Q · Quarterly reportAug 16, 2021Quarterly reportSEC
4 · Change in ownershipJun 4, 2021Insider tradeSEC
4 · Change in ownershipJun 4, 2021Insider tradeSEC
4 · Change in ownershipJun 4, 2021Insider tradeSEC
8-K · Current reportJun 2, 2021Material contractSEC
424B4 · ProspectusJun 1, 2021Offer documentSEC

This page holds 200 of 757 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Zivo Bioscience, Inc.’s releases

Common shares
4,215,112
Fully diluted
4,215,112

Fully diluted

LineShares
Common shares4,215,112

Share count over time

CountShares
Nov 22, 20264,215,112

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Alison A Cornell
Other companies: International Flavors & Fragrances, Inc. (EVP & CFO · May 2, 2016 – May 2, 2016 · Past)
Director · Since at least Feb 8, 2021
John B. Payne
Other companies: Nexvet Biopharma plc (Director · Feb 4, 2015 – Jul 31, 2017 · Past)
President / Chief Executive Officer / Chairman of the Board · Since at least Jul 19, 2013
John D Crissman
Other companies: Caraco Pharmaceutical Laboratories Ltd (Director · Jul 20, 2006 – Jul 20, 2009 · Past)
Director · Oct 13, 2010 – Jul 1, 2011 · Past
Amy SteffekDirector, Research & Development · Since at least Nov 5, 2026
Andrew A DahlPresident / CEO, Director · Dec 16, 2011 – Oct 21, 2021 · Past
Christopher MaggioreDirector · Since at least Dec 13, 2023
Keith MarchiandoChief Financial Officer · Jan 1, 2021 – Jun 5, 2024 · Past
Laith YaldooDirector since 2024 · Since at least Jul 11, 2024
Nola E MastersonDirector · Jun 5, 2024 – Jan 1, 2025 · Past
Philip M Rice IIChief Financial Officer · Nov 4, 2011 – Apr 8, 2020 · Past
All 11 people
PersonSeat
William A SullivanChief Financial Officer · Since at least Dec 19, 2025

Open People

Log in to ask 6ix AI your own questions about Zivo Bioscience, Inc.